Application 203018

Type
ANDA
Sponsor
SCIEGEN PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDETABLET;ORAL25MGNoNo
002HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDETABLET;ORAL50MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50228-111HydrochlorothiazideHydrochlorothiazideScieGen Pharmaceuticals, Inc.ANDACurrent
50228-111HydrochlorothiazideHydrochlorothiazideScieGen Pharmaceuticals, Inc.ANDACurrent
50228-111HydrochlorothiazideHydrochlorothiazideScieGen Pharmaceuticals, Inc.ANDACurrent
50228-112HydrochlorothiazideHydrochlorothiazideScieGen Pharmaceuticals, Inc.ANDACurrent
50228-112HydrochlorothiazideHydrochlorothiazideScieGen Pharmaceuticals, Inc.ANDACurrent
50228-112HydrochlorothiazideHydrochlorothiazideScieGen Pharmaceuticals, Inc.ANDACurrent
60429-214HydrochlorothiazideHydrochlorothiazideGolden State Medical Supply, IncANDACurrent
60429-215HydrochlorothiazideHydrochlorothiazideGolden State Medical Supply, IncANDACurrent
69367-122HydrochlorothiazideHydrochlorothiazideWestminster Pharmaceuticals, LLCANDACurrent
69367-122HydrochlorothiazideHydrochlorothiazideWestminster Pharmaceuticals, LLCANDACurrent
69367-123HydrochlorothiazideHydrochlorothiazideWestminster Pharmaceuticals, LLCANDACurrent
69367-123HydrochlorothiazideHydrochlorothiazideWestminster Pharmaceuticals, LLCANDACurrent